Elevated liver enzymes seen in COVID-19 patients from a meta-analysis were characterized by a prevalence of AST (23.2%), ALT (21.2%), GGT (15.0%), bilirubin (9.7%), and ALP (4.0%), respectively [64]. The gene discussed is GPT; the disease is COVID-19.